Structures by: Wu N.
Total: 42
2(C36H22IrN6S2),2(F6P)
2(C36H22IrN6S2),2(F6P)
Journal of medicinal chemistry (2019) 62, 7 3311-3322
a=13.4535(8)Å b=16.0914(11)Å c=19.2715(11)Å
α=111.899(2)° β=93.037(2)° γ=111.657(2)°
C34H24F4IrN4O2,F6P,CH2Cl2
C34H24F4IrN4O2,F6P,CH2Cl2
Chem. Sci. (2017) 8, 1 631
a=9.39650(10)Å b=39.4086(6)Å c=9.8195(2)Å
α=90° β=104.761(2)° γ=90°
Y Ba2 Cu3 O6.7
Ba2Cu3O6.7Y
Scientia Sinica, Series B (1988) 31, 513-522
a=3.893Å b=3.813Å c=11.687Å
α=90° β=90° γ=90°
C22H25NO3
C22H25NO3
Organic letters (2014) 16, 15 4048-4051
a=9.615(7)Å b=10.042(8)Å c=10.834(8)Å
α=87.159(13)° β=87.752(13)° γ=73.682(12)°
C18H13F3O9S
C18H13F3O9S
Organic letters (2009) 11, 20 4628-4631
a=18.964(5)Å b=13.633(3)Å c=29.823(6)Å
α=90.00° β=92.316(16)° γ=90.00°
(R)-1-bromo-4-(2-nitro-1-(p-tolyl)ethyl)benzene
C15H14BrNO2
Organic & biomolecular chemistry (2016) 14, 47 11080-11084
a=5.4842(15)Å b=15.284(4)Å c=16.885(5)Å
α=90.00° β=90.00° γ=90.00°
C17H20ClN
C17H20ClN
Organic & biomolecular chemistry (2016) 14, 3 920-939
a=9.547(3)Å b=7.1510(19)Å c=12.171(3)Å
α=90.00° β=111.479(3)° γ=90.00°
2(C79H57Cl4CoF8N3)
2(C79H57Cl4CoF8N3)
Dalton transactions (Cambridge, England : 2003) (2020) 49, 27 9425-9437
a=16.65280(10)Å b=25.4947(2)Å c=35.8638(2)Å
α=90° β=97.8590(10)° γ=90°
C81H60ClCoF10N3O2
C81H60ClCoF10N3O2
Dalton transactions (Cambridge, England : 2003) (2020) 49, 27 9425-9437
a=18.5816(3)Å b=27.4361(2)Å c=16.5226(3)Å
α=90° β=116.265(2)° γ=90°
C79H65Cl2CoF2N3,CH2Cl2,C4H8O
C79H65Cl2CoF2N3,CH2Cl2,C4H8O
Dalton transactions (Cambridge, England : 2003) (2020) 49, 27 9425-9437
a=10.4294(4)Å b=18.2182(7)Å c=20.3353(7)Å
α=65.813(4)° β=76.760(4)° γ=81.879(3)°
2(C79H57Cl2CoF10N3),C4H10O
2(C79H57Cl2CoF10N3),C4H10O
Dalton transactions (Cambridge, England : 2003) (2020) 49, 27 9425-9437
a=15.6079(2)Å b=28.3387(4)Å c=33.8316(5)Å
α=90° β=92.5730(10)° γ=90°
C28H24IrN6,CF3O3S,CH2Cl2
C28H24IrN6,CF3O3S,CH2Cl2
Dalton transactions (Cambridge, England : 2003) (2017) 46, 39 13482-13491
a=24.0303(3)Å b=15.9300(2)Å c=17.5507(3)Å
α=90° β=90° γ=90°
C17H18F6N3P
C17H18F6N3P
Chemical communications (Cambridge, England) (2020) 56, 94 14853-14856
a=6.35200(10)Å b=8.22740(10)Å c=33.0348(6)Å
α=90° β=91.2980(10)° γ=90°
C23H22F6N3P
C23H22F6N3P
Chemical communications (Cambridge, England) (2020) 56, 94 14853-14856
a=30.1428(6)Å b=6.19510(10)Å c=23.4009(4)Å
α=90° β=93.329(2)° γ=90°
C23H20FNO2S
C23H20FNO2S
Chemical Communications (2019)
a=13.009(7)Å b=9.880(5)Å c=15.062(8)Å
α=90° β=92.898(8)° γ=90°
WHU-3
C6H10CuN2O4,2(H2O)
Journal of Materials Chemistry A (2017) 5, 45 23440
a=5.222(2)Å b=8.635(4)Å c=11.558(5)Å
α=90.00° β=100.115(5)° γ=90.00°
Cu-(Gly-Thr)
C6H10CuN2O4
Journal of Materials Chemistry A (2017) 5, 45 23440
a=5.2865(7)Å b=8.7180(11)Å c=17.773(4)Å
α=90.00° β=90.00° γ=90.00°
C28H24BCuF4N8
C28H24BCuF4N8
Chemical communications (Cambridge, England) (2010) 46, 44 8454-8456
a=13.2589(6)Å b=11.2087(5)Å c=19.7397(8)Å
α=90.00° β=108.960(2)° γ=90.00°
PTCDI-C6 and coronene cocrystal
C36H30N2O4,C24H12
RSC Adv. (2016)
a=7.251(3)Å b=10.585(3)Å c=14.082(4)Å
α=78.553(14)° β=78.630(17)° γ=78.805(17)°
C23H30O6
C23H30O6
Chemical Communications (Cambridge, United Kingdom) (2009) 34, 6 662-664
a=10.306(2)Å b=11.417(2)Å c=11.436(2)Å
α=105.05(3)° β=111.60(3)° γ=110.32(3)°
C21H26O5
C21H26O5
Chemical Communications (Cambridge, United Kingdom) (2009) 34, 6 662-664
a=9.2758(19)Å b=9.802(2)Å c=20.869(4)Å
α=90.00° β=102.05(3)° γ=90.00°
1-tert-butylindeno(2,1-c)pyran-3,9-dione
C16H14O3
Chem.Commun. (2012) 48, 9986
a=12.2272(14)Å b=14.8729(17)Å c=6.6914(8)Å
α=90.00° β=90.00° γ=90.00°
1-cyclopentyl-indeno(2,1-c)pyran-3,9-dione
C17H14O3
Chem.Commun. (2012) 48, 9986
a=5.2209(5)Å b=10.1676(10)Å c=12.1963(12)Å
α=99.81(2)° β=93.34(2)° γ=98.10(2)°
Ethyl 2-(2-(cyclohexylidenemethyl)-1-oxo-1H-inden-3-yl)acetate
C20H22O3
Chem.Commun. (2012) 48, 9986
a=10.5444(3)Å b=16.3175(5)Å c=10.4557(3)Å
α=90.00° β=115.377(7)° γ=90.00°
C18H10O3
C18H10O3
Chem.Commun. (2012) 48, 9986
a=3.7461(4)Å b=32.774(3)Å c=10.2441(10)Å
α=90° β=99.745(4)° γ=90°
C51H48Fe2N24,4(BF4),3(C2H3N),H2O
C51H48Fe2N24,4(BF4),3(C2H3N),H2O
Dalton transactions (Cambridge, England : 2003) (2015) 44, 33 14991-15005
a=13.8603(5)Å b=17.9020(7)Å c=17.9413(7)Å
α=109.535(2)° β=101.234(3)° γ=103.518(2)°
1
C34H22Cl2F4IrN4,F6P,C3H6O
Chem. Sci. (2017) 8, 1 631
a=10.5808(4)Å b=13.0767(5)Å c=14.3976(6)Å
α=93.447(3)° β=106.228(4)° γ=97.527(3)°
2(C34H27.50IrN4O2),F6P
2(C34H27.50IrN4O2),F6P
Chem. Sci. (2017) 8, 1 631
a=39.1832(11)Å b=9.6185(2)Å c=19.2745(5)Å
α=90° β=109.894(2)° γ=90°
2-Amino-4-(4-methoxyphenyl)-5-oxo-4H,5H-pyrano[3,2-c]chromene-3-carbonitrile N,N-dimethylformamide solvate
C20H14N2O4,C3H7NO
Acta Crystallographica Section E (2004) 60, 12 o2359-o2361
a=12.472(3)Å b=13.003(3)Å c=13.620(3)Å
α=99.799(4)° β=95.399(4)° γ=104.785(5)°
2-Amino-4-(3,4-dichlorophenyl)-4H-pyrano[3,2-c]coumarin-3-carbonitrile N,N-dimethylformamide solvate
C19H10Cl2N2O3,C3H7NO
Acta Crystallographica Section E (2004) 60, 12 o2339-o2341
a=28.126(6)Å b=7.8824(13)Å c=22.096(5)Å
α=90.00° β=122.493(3)° γ=90.00°
Methyl 2-amino-4-(4-chlorophenyl)-4H-pyrano[3,2-c]coumarin-3-carboxylate N,N-dimethylformamide solvate
C20H14ClNO5,C3H7NO
Acta Crystallographica Section E (2005) 61, 1 o87-o89
a=7.5757(5)Å b=12.7812(4)Å c=12.9142(8)Å
α=62.186(5)° β=89.802(8)° γ=74.080(6)°
1-<i>n</i>-Butylindeno[2,1-<i>c</i>]pyran-3,9-dione
C16H14O3
Acta Crystallographica Section C (2012) 68, 10 o413-o416
a=4.6539(6)Å b=10.1800(12)Å c=14.3718(17)Å
α=82.481(5)° β=88.127(7)° γ=78.604(6)°
1-<i>n</i>-Butylindeno[2,1-<i>c</i>]pyran-3,9-dione
C16H14O3
Acta Crystallographica Section C (2012) 68, 10 o413-o416
a=5.3708(2)Å b=7.2029(3)Å c=16.9507(8)Å
α=96.461(2)° β=93.246(2)° γ=110.029(2)°
1-<i>n</i>-Butylindeno[2,1-<i>c</i>]pyran-3,9-dione
C16H14O3
Acta Crystallographica Section C (2012) 68, 10 o413-o416
a=5.4330(3)Å b=7.2863(4)Å c=17.0874(9)Å
α=97.426(2)° β=92.884(2)° γ=108.874(2)°
2-(3,4-Dichlorophenyl)-4-phenylbenzo[<i>h</i>]quinoline
C25H15Cl2N
Acta Crystallographica Section E (2011) 67, 11 o2850
a=10.6066(14)Å b=9.5667(12)Å c=18.824(2)Å
α=90.00° β=94.264(7)° γ=90.00°
4-(4-Bromophenyl)-2,3,3a,4,5,11c-hexahydrobenzo[<i>f</i>]furo[3,2- <i>c</i>]quinoline
C21H18BrNO
Acta Crystallographica Section E (2011) 67, 9 o2285
a=9.4019(2)Å b=9.6025(2)Å c=10.4660(2)Å
α=103.8880(10)° β=114.0750(10)° γ=92.4690(10)°
2-(2-<i>p</i>-Tolylbenzo[<i>g</i>]quinolin-3-yl)ethanol
C22H19NO
Acta Crystallographica Section E (2011) 67, 10 o2770
a=7.2044(4)Å b=10.1704(4)Å c=12.1194(3)Å
α=108.125(3)° β=98.115(4)° γ=99.370(5)°
Diaquabis[5-(pyrazin-2-yl-κ<i>N</i>^1^)-3-(pyridin-4-yl)-1<i>H</i>-1,2,4- triazol-1-ido-κ<i>N</i>^1^]cobalt(II) methanol disolvate
C22H18CoN12O2,2(CH4O)
Acta Crystallographica Section E (2012) 68, 5 m600
a=11.462(9)Å b=7.121(5)Å c=16.116(12)Å
α=90.00° β=95.418(14)° γ=90.00°
C18H14F0N2O0
C18H14F0N2O0
The Journal of organic chemistry (2020) 85, 6 4536-4542
a=16.003(3)Å b=7.6071(15)Å c=11.779(2)Å
α=90.00° β=108.82(3)° γ=90.00°
C10H13Cl3CoN4
C10H13Cl3CoN4
Crystal Growth & Design (2006) 6, 1 229
a=13.2160(9)Å b=8.1166(8)Å c=14.0262(9)Å
α=90.00° β=106.236(4)° γ=90.00°
C10H12Cl3CoN4
C10H12Cl3CoN4
Crystal Growth & Design (2006) 6, 1 229
a=8.0925(16)Å b=9.1700(18)Å c=10.819(2)Å
α=89.10(3)° β=86.28(3)° γ=64.01(3)°
1-Butylindeno(2,1-c)pyran-3,9-dione
C16H14O3
Chem.Commun. (2012) 48, 9986
a=5.3708(2)Å b=7.2029(3)Å c=16.9507(8)Å
α=96.461(2)° β=93.246(2)° γ=110.029(2)°